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Recently, we and others have shown mechanistically how metal-
organic frameworks (MOFs) are biomimetically formed on the 
surface of proteins and, once encapsulated, these 
bionanoparticles show dramatic enhanced thermal stability and 
resistance to denaturation in organic solvents. Earlier this year 
my colleagues and I presented a perspective (ACS Nano 2018, 1, 
13–23) on a vision of how this nanotechnology could help “break 
the cold chain” with regards to vaccine delivery. Over the 
intervening months, we have come to realize we sold our vision 
short in this perspective—bionanomaterials formed via this 
method is capable of more. Specifically, as we report, ZIF-8 
nano-structured proteins are near ideal candidates for controlled 
delivery of native proteins via subcutaneous implantation while 
protecting them in vivo against premature degradation. This 
would challenge the status quo for therapeutic protein delivery 
because vaccines are the largest market for therapeutic proteins 
in the world and they are one of the few medicines that are both 
shipped to places where 24-hour refrigeration is required yet not 
always available. Further, vaccines often require multiple 
administrations which means that a patient needs to return to a 
doctor. It has been suggested, however, that slow administration 
via time-release of vaccines may be a way to skip these multiple 
trips to the doctors. In developing nations, where infrastructure 
and trained medical professionals are scarce, this could be a 
lifesaving boon.  
 
I will be discussing the comprehensively studied the thermal and 
chemical stability of MOF-based protein composites using a pre-
clinical vaccine model based on tobacco mosaic virus (TMV). We 
demonstrate that biomimetic mineralization of ZIF-8 does not alter 
antibody binding to surface epitopes of the viral nanoparticle even 
after exposing the composite to 100 °C temperatures for 20 
minutes. We then demonstrate that our MOF-vaccine composite, 
can be directly injected into mice, produces a more linear dose 
response, and elicits an improved immune response as 
compared to pristine virus. Imaging data show that ZIF-8 actually 
helps prolong release of the TMV over time, and we get a slightly 
improved immune response thanks to this unique drug delivery 
method. Histology shows the animal is left unharmed from even 
repeated administrations of the TMV@ZIF composite. Taken 
together, these data strongly suggest ZIF-8 based shells may 
provide a method to concurrently protect and deliver 
proteinaceous drugs safely. 
 
Top: SEM images of TMV@ZIF a) non-
stressed, b) heating at 100 °C for 20 
min, and after soaking overnight in c) 
methanol, d) 6 M guanidinium chloride, 
and e) ethyl acetate. Scale bars 
represent 2 µm. f) TEM image of 
exfoliated non-stressed TMV. Scale bar 
is 200 nm. Bottom: The ELISA response 
of naked and encapsulated TMV subject 
to no stress (a), heating (b), methanol 
(c), 6 M guanidinium chloride (d), and 
ethyl acetate (e). The percentages range 
from buffer blank (0% TMV) to non-
stressed naked TMV (100% TMV). 
 
